An overview of the key physiological barriers to oral delivery of biologics and the strategies to overcome them that are currently being tested.
An overview of the anticancer agents that have been approved for use in the UK as part of a precision medicine approach for solid tumours, along with information relating to the relevant biomarkers and biomarker assays currently available.
Severe bone damage in the jaw occurs in some people as an adverse reaction to certain medicines commonly used in the treatment of cancer and osteoporosis. There are a range of settings where pharmacists can contribute to the prevention of this painful and difficult-to-treat condition.
A review of the pros and cons of oral anticancer drug therapy, as well as the pharmacokinetic barriers and potential solutions to oral chemotherapy in the home.
A pharmacy-led medicines optimisation team in a GP surgery setting reduced inappropriate polypharmacy, achieved cost savings of £103,975 and improved quality of prescribing for patients.
A Portsmouth-based medicines advice at home service highlights the impact of pharmacist-led interventions.
A cross-sectional survey assessing adherence medication-assisted treatment for opioid use disorder, and the predictors of risk of poor adherence.
Pharmaceutical care to medical patients in the emergency department: a service evaluationSubscription
An evaluation of a new hospital pharmacy service that introduces pharmaceutical care earlier after admission to the emergency department.
Economic, manufacturing and regulatory factors can affect drug shortages and supply chain disruption. By using a mixed-methods approach involving an online survey, semi-structured interviews and three targeted focus groups aimed at acute care hospitals in England, Wales, Northern Ireland and Ireland, this study determined that over half of the responding acute care hospitals did not have 76–100% of medicine lines fulfilled within 8 weeks of a disruption in the supply chain.
The appropriate use of medicines is dependant on the accurate use of clinical indications on inpatient paper and electronic prescriptions. This mixed-methods study involving semi-structured interviews with 64 chief pharmacists, 11 focus groups from three NHS trusts and a medical documentation review of 89 patients determined both positive and negative implications of including clinical indications on healthcare professionals’ clinical workflow.